Skip to main content
Veterinary Medicines

CANVAC JUNIOR, Lyofilizát a rozpouštědlo pro injekční suspenzi

Authorised
  • Canine distemper virus, Live
  • Canine parvovirus, Live

Product identification

Medicine name:
CANVAC JUNIOR, Lyofilizát a rozpouštědlo pro injekční suspenzi
Active substance:
  • Canine distemper virus, Live
  • Canine parvovirus, Live
Target species:
  • Dog (puppy)
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine distemper virus, Live
    4.50
    log 10 50% embryo infective dose
    /
    1.00
    Dose
  • Canine parvovirus, Live
    2048.00
    haemagglutinating units
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog (puppy)
    • Dog
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Dyntec spol. s r.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dyntec spol. s r.o.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicines
Authorisation number:
  • 97/1157/97-C
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."